Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20190224042815N1Phase 3Not yet recruiting
Phase 3, randomised, double-blind trial in delirium comparing Thiamine with Placebo (2 arms). Primary endpoints: Prevention of delirium, Hospitalization time and 1 more. Planned start May 2640; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20190224042815N1.